Corbus Pharmaceuticals Holdings CRBP
NASDAQ CRBP
$4.05 -0.08 (-1.94%)
At close: Oct 23, 2026 · 4:00 PM EDT

Corbus Pharmaceuticals Holdings (CRBP) Cash & Equivalents (2013 - 2025)

Updated

Corbus Pharmaceuticals Holdings' Cash & Equivalents came in at $28.49 million for Q4 2025, up 65.7% from $17.2 million a year earlier and up 5.6% from the prior quarter.

Analysis

Corbus Pharmaceuticals Holdings (CRBP) Cash & Equivalents (2013 - 2025) Analysis & Trends

Going back to Q3 2013, Corbus Pharmaceuticals Holdings' Cash & Equivalents data covers 50 quarters.

  • Cash & Equivalents carries a five-year compound annual growth rate of -19.7% (FY2020 to FY2025).
  • Going back by year, Cash & Equivalents was $17.2 million in FY2024 (+25.3%), $13.72 million in FY2023 (-19.3%), $17 million in FY2022 (-32.0%) and $25.01 million in FY2021 (-70.7%).
  • The Q4 2025 figure represents the highest quarterly Cash & Equivalents since Q1 2022.
  • Year-over-year, Cash & Equivalents increased in seven of the last eight quarters, with growth averaging 62.2%.
  • The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2024 (growth of 183.7%), and the weakest in Q1 2023 (a decline of 87.2%).
  • Business Quant data shows CRBP's Cash & Equivalents at $26.98 million (Q3 2025), $20.04 million (Q2 2025) and $18.9 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 16.91 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 976.00 Mn
10 Corbus Pharmaceuticals Holdings 49.84 Mn -466.79 Mn - 28.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 28.49 Mn
Sep 30, 2025 26.98 Mn
Jun 30, 2025 20.04 Mn
Mar 31, 2025 18.90 Mn
Dec 31, 2024 17.20 Mn
Sep 30, 2024 19.42 Mn
Jun 30, 2024 23.69 Mn
Mar 31, 2024 14.10 Mn
Dec 31, 2023 13.72 Mn
Sep 30, 2023 11.25 Mn
Jun 30, 2023 8.35 Mn
Mar 31, 2023 7.32 Mn
Dec 31, 2022 17.00 Mn
Sep 30, 2022 12.44 Mn
Jun 30, 2022 25.77 Mn
Mar 31, 2022 57.03 Mn
Dec 31, 2021 25.01 Mn
Sep 30, 2021 37.12 Mn
Jun 30, 2021 36.08 Mn
Mar 31, 2021 66.61 Mn
API Access

Corbus Pharmaceuticals Holdings Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CRBP&period=max&api_key=YOUR_API_KEY